share_log

Aslan Pharmaceuticals | 424B5: Prospectus

SEC announcement ·  Oct 9, 2020 17:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more